BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Kaempferol Alleviates Murine Experimental Colitis by Restoring Gut Microbiota and Inhibiting the LPS-TLR4-NF-?B Axis. ✅
Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 12 Issue Pages: 679897 Pub: 2021 Epub: 2021 Jul 22 Authors Qu Y , Li X , Xu F , Zhao S , Wu X , Wang Y , Xie J , |
|
|
Kaempferol Alleviates Murine Experimental Colitis by Restoring Gut Microbiota and Inhibiting the LPS-TLR4-NF-?B Axis. ✅
Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 12 Issue Pages: 679897 Pub: 2021 Epub: 2021 Jul 22 Authors Qu Y , Li X , Xu F , Zhao S , Wu X , Wang Y , Xie J , |
|
|
Kaempferol Alleviates Murine Experimental Colitis by Restoring Gut Microbiota and Inhibiting the LPS-TLR4-NF-?B Axis. ✅
Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 12 Issue Pages: 679897 Pub: 2021 Epub: 2021 Jul 22 Authors Qu Y , Li X , Xu F , Zhao S , Wu X , Wang Y , Xie J , |
|
|
Preventive Effects of Kaempferol on High-Fat Diet-Induced Obesity Complications in C57BL/6 Mice. ✅
Go to Publication ✅
BioMed research international (Biomed Res Int ) Vol: 2020 Issue Pages: 4532482 Pub: 2020 Epub: 2020 Apr 7 Authors Wang T , Wu Q , Zhao T , |
|
|
Anti-inflammatory effects of Kaempferol on Helicobacter pylori-induced inflammation. ✅
Go to Publication ✅
Bioscience, biotechnology, and biochemistry (Biosci Biotechnol Biochem ) Vol: 83 Issue 1 Pages: 166-173 Pub: 2019 Jan Epub: 2018 Oct 5 Authors Yeon MJ , Lee MH , Kim DH , Yang JY , Woo HJ , Kwon HJ , Moon C , Kim SH , Kim JB , |
|
|
Potential mechanisms underlying inhibition of xenograft lung cancer models by kaempferol: modulation of gut microbiota in activating immune cell function. ✅
Go to Publication ✅
Journal of Cancer (J Cancer ) Vol: 15 Issue 5 Pages: 1314-1327 Pub: 2024 Epub: 2024 Jan 15 Authors Guan M , Xu W , Bai H , Geng Z , Yu Z , Li H , Liu T , |
|
|
Potential mechanisms underlying inhibition of xenograft lung cancer models by kaempferol: modulation of gut microbiota in activating immune cell function. ✅
Go to Publication ✅
Journal of Cancer (J Cancer ) Vol: 15 Issue 5 Pages: 1314-1327 Pub: 2024 Epub: 2024 Jan 15 Authors Guan M , Xu W , Bai H , Geng Z , Yu Z , Li H , Liu T , |
|
|
Potential mechanisms underlying inhibition of xenograft lung cancer models by kaempferol: modulation of gut microbiota in activating immune cell function. ✅
Go to Publication ✅
Journal of Cancer (J Cancer ) Vol: 15 Issue 5 Pages: 1314-1327 Pub: 2024 Epub: 2024 Jan 15 Authors Guan M , Xu W , Bai H , Geng Z , Yu Z , Li H , Liu T , |
|
|
Potential mechanisms underlying inhibition of xenograft lung cancer models by kaempferol: modulation of gut microbiota in activating immune cell function. ✅
Go to Publication ✅
Journal of Cancer (J Cancer ) Vol: 15 Issue 5 Pages: 1314-1327 Pub: 2024 Epub: 2024 Jan 15 Authors Guan M , Xu W , Bai H , Geng Z , Yu Z , Li H , Liu T , |
|
|
Rebalancing of the gut flora and microbial metabolism is responsible for the anti-arthritis effect of kaempferol. ✅
Go to Publication ✅
Acta pharmacologica Sinica (Acta Pharmacol Sin ) Vol: 41 Issue 1 Pages: 73-81 Pub: 2020 Jan Epub: 2019 Aug 19 Authors Aa LX , Fei F , Qi Q , Sun RB , Gu SH , Di ZZ , Aa JY , Wang GJ , Liu CX , |
|
|
Rebalancing of the gut flora and microbial metabolism is responsible for the anti-arthritis effect of kaempferol. ✅
Go to Publication ✅
Acta pharmacologica Sinica (Acta Pharmacol Sin ) Vol: 41 Issue 1 Pages: 73-81 Pub: 2020 Jan Epub: 2019 Aug 19 Authors Aa LX , Fei F , Qi Q , Sun RB , Gu SH , Di ZZ , Aa JY , Wang GJ , Liu CX , |
|
|
Rebalancing of the gut flora and microbial metabolism is responsible for the anti-arthritis effect of kaempferol. ✅
Go to Publication ✅
Acta pharmacologica Sinica (Acta Pharmacol Sin ) Vol: 41 Issue 1 Pages: 73-81 Pub: 2020 Jan Epub: 2019 Aug 19 Authors Aa LX , Fei F , Qi Q , Sun RB , Gu SH , Di ZZ , Aa JY , Wang GJ , Liu CX , |
|
|
Rebalancing of the gut flora and microbial metabolism is responsible for the anti-arthritis effect of kaempferol. ✅
Go to Publication ✅
Acta pharmacologica Sinica (Acta Pharmacol Sin ) Vol: 41 Issue 1 Pages: 73-81 Pub: 2020 Jan Epub: 2019 Aug 19 Authors Aa LX , Fei F , Qi Q , Sun RB , Gu SH , Di ZZ , Aa JY , Wang GJ , Liu CX , |
|
|
Rebalancing of the gut flora and microbial metabolism is responsible for the anti-arthritis effect of kaempferol. ✅
Go to Publication ✅
Acta pharmacologica Sinica (Acta Pharmacol Sin ) Vol: 41 Issue 1 Pages: 73-81 Pub: 2020 Jan Epub: 2019 Aug 19 Authors Aa LX , Fei F , Qi Q , Sun RB , Gu SH , Di ZZ , Aa JY , Wang GJ , Liu CX , |
|
|
Rebalancing of the gut flora and microbial metabolism is responsible for the anti-arthritis effect of kaempferol. ✅
Go to Publication ✅
Acta pharmacologica Sinica (Acta Pharmacol Sin ) Vol: 41 Issue 1 Pages: 73-81 Pub: 2020 Jan Epub: 2019 Aug 19 Authors Aa LX , Fei F , Qi Q , Sun RB , Gu SH , Di ZZ , Aa JY , Wang GJ , Liu CX , |
|
|
Therapeutic potential of kaempferol on Streptococcus pneumoniae infection. ✅
Go to Publication ✅
Microbes and infection (Microbes Infect ) Vol: 25 Issue 3 Pages: 105058 Pub: 2023 Mar-Apr Epub: 2022 Oct 7 Authors Xu L , Fang J , Ou D , Xu J , Deng X , Chi G , Feng H , Wang J , |
|
|
The Prebiotic Effect of Kaempferol in Regulating Bile Acid Metabolism. ✅
Go to Publication ✅
Food science & nutrition (Food Sci Nutr ) Vol: 13 Issue 3 Pages: e70023 Pub: 2025 Mar Epub: 2025 Feb 24 Authors Li X , Huang G , Khan I , Ding Z , Hsiao WLW , Liu Z , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
